Quick Answer
Odyssey Health, Inc. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2025.
Odyssey Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.02 | -100.0% |
| 2024 | -$0.01 | +85.7% |
| 2023 | -$0.07 | +22.2% |
| 2022 | -$0.09 | +50.0% |
| 2021 | -$0.18 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$0.03 | — | — |
| October 31, 2025 | $0.00 | +100.0% | — |
| April 30, 2025 | $0.00 | +100.0% | — |
| January 31, 2025 | $0.00 | -100.0% | +100.0% |
| October 31, 2024 | -$0.01 | +0.0% | +0.0% |
| April 30, 2024 | -$0.01 | +50.0% | -108.3% |
| January 31, 2024 | $0.12 | +700.0% | +1300.0% |
| October 31, 2023 | -$0.01 | +66.7% | +50.0% |
- Odyssey Health, Inc. showed a decrease of -100.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Odyssey Health, Inc.’s diluted eps has grown by 88.9% (from $0.18 per share (loss) to $0.02 per share (loss)).
- The most recent figure is from Odyssey Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: